Korea Stock Market Insights

Tag: 098460

(098460) KohYoung Technology Investment Analysis (098460): Stock Value, Dividends & Future Growth
A sound KohYoung Technology investment strategy requires looking beyond headlines. Recently, the company (ticker: 098460) announced a change to its dividend record date, causing some investors to question its impact on stock value and future returns. While this procedural shift is noteworthy, it barely scratches the surface of the company’s true intrinsic value. This comprehensive KohYoung Technology analysis will dissect the meaning of this change, evaluate the company’s powerful core business, examine its financial stability, and outline a clear investment thesis based on its future growth engines.

Unpacking the Dividend Record Date Change

At its Annual General Meeting on March 28, 2024, KohYoung amended its Articles of Incorporation. The core change shifts the power to set the dividend record date from a fixed calendar day to a flexible decision made by the Board of Directors. This update was formally detailed in an Official Disclosure (Source) on the DART system.

Previously: Dividend eligibility was tied to holding shares on the last day of the fiscal year (December 31st).
After Change: Starting with the 2025 fiscal year-end dividend, eligibility requires holding shares on a specific date chosen and announced by the Board.

For investors, this means the old strategy of buying 098460 stock just before year-end no longer guarantees a dividend payout. While this introduces a slight reduction in predictability, it aligns the company with modern governance practices, granting it greater flexibility in capital management. Ultimately, this change is a procedural footnote and has a very limited direct impact on KohYoung’s fundamental business operations, revenue, or long-term profitability.

A Deep Dive into KohYoung’s Core Business Value

To truly assess a KohYoung Technology investment, we must focus on its powerful market position and technological leadership. The company’s value is built on a foundation of innovation in high-precision inspection and robotics.

The Global Leader: 3D Inspection Systems (SPI & AOI)

KohYoung is the undisputed global market leader in 3D Solder Paste Inspection (SPI) and Automated Optical Inspection (AOI) equipment. This technology is critical for electronics manufacturing, ensuring the quality of circuit boards used in everything from smartphones to electric vehicles. The company’s competitive edge is sharpened by its KSMART platform, which leverages AI to create a smart factory ecosystem, optimizing production lines and minimizing defects. This integration is key to their goal of capturing 70% of the market share.

The Next Frontier: ‘Geniant Cranial’ Medical Robot

A significant future growth engine is KohYoung’s expansion into the medical device sector. The company’s brain surgery medical robot, ‘Geniant Cranial,’ recently received US FDA 510(k) clearance. This is a monumental achievement that opens the door to the lucrative global healthcare market. This diversification not only provides a new revenue stream but also positions KohYoung at the forefront of the high-growth med-tech industry, a factor many KohYoung Technology stock analyses are watching closely.

Financial Health & R&D: A Stable Foundation for Growth

While revenue has seen fluctuations tied to the broader semiconductor cycle, KohYoung’s financial structure is remarkably robust. A deep dive into the numbers reveals a company built for the long haul. For context on industry financial health, investors can consult sources like Bloomberg’s market data.
- •Excellent Financial Stability: With a debt-to-equity ratio of just 38.67% and a current ratio of 220.61% (as of year-end 2024), the company has very low debt and ample liquidity to weather economic downturns and fund growth initiatives.
- •Commitment to Innovation: KohYoung consistently invests over 20% of its sales into Research & Development. This high R&D expenditure is a direct investment in maintaining its technological lead and developing future products like the Geniant Cranial robot.
- •Return to Profitability: After a challenging period, the company returned to profitability in the first half of 2025, signaling a positive operational turnaround. Investors should continue to monitor this trend.
Investment Thesis: Opportunities vs. Risks

A balanced KohYoung Technology investment outlook considers both the significant opportunities and the potential risks. For more on this, you can read our guide to investing in the semiconductor industry.

Positive Investment Points
- •Unrivaled technology and #1 market share in its core business.
- •Significant growth potential from the new medical robotics division.
- •Strengthening competitive edge through AI-powered KSMART solutions.
- •Extremely stable financial health and a strong commitment to R&D.
Risk Factors to Monitor
- •Exposure to the cyclical nature of the global IT and semiconductor industries.
- •Delayed profitability improvements could test investor patience.
- •Intensifying competition in the 3D inspection equipment market.
Conclusion: A ‘Neutral’ Stance with Long-Term Potential

In conclusion, the KohYoung Technology dividend record date change is a minor event that should not be the primary driver of your investment decision. The company’s fundamental strengths—market leadership, technological innovation, financial stability, and new growth ventures in med-tech—are far more significant. The overall investment opinion remains ‘Neutral’ for the short term, pending sustained evidence of profitability and market traction from new business segments. Prudent investors should monitor these key performance indicators closely, as KohYoung Technology possesses the core ingredients for significant long-term growth.
11/12/2025
(098460) KohYoung Technology Inc. Earnings (098460): Q3 2025 Surprise Signals a Major Turnaround
The latest KohYoung Technology Inc. earnings report for Q3 2025 has captured significant attention across the market, delivering a stunning ‘earnings surprise’ that surpassed all analyst expectations. For investors conducting an 098460 stock analysis, this moment raises a critical question: is this a temporary bright spot or the beginning of a sustainable, long-term turnaround for the 3D inspection leader? This comprehensive analysis will dissect KohYoung’s Q3 results, explore the fundamental drivers behind the performance, evaluate the company’s competitive position, and outline strategic considerations for potential investors.

Unpacking the Q3 2025 ‘Earnings Surprise’

KohYoung Technology Inc. announced preliminary consolidated results for the third quarter of 2025 that demonstrated a remarkable recovery and profitability, decisively beating market consensus. The performance signifies a potent rebound from the sluggishness observed in late 2024 and early 2025.

The successful return to a strong net profit is the clearest indicator yet of KohYoung’s strengthening operational health and potential for a full-fledged business turnaround.

Key Financial Highlights vs. Market Estimates
- •Revenue: KRW 60.3 billion, a significant 9.0% above the market estimate of KRW 55.3 billion.
- •Operating Profit: KRW 4.7 billion, soaring 38.2% above the market estimate of KRW 3.4 billion.
- •Net Profit: KRW 8.5 billion, an impressive 57.4% above the market estimate of KRW 5.4 billion.
These figures are not just numbers on a page; they represent a significant operational achievement. The full preliminary results can be found in their Official Disclosure filed with DART.

Fundamental Drivers of the KohYoung Earnings Surprise

The strong quarterly performance is not an accident but the result of strategic execution across key business segments and favorable trends in the high-growth 3D inspection equipment market.

Robust Growth in 3D SPI (Solder Paste Inspection)

The 3D SPI segment was a star performer, registering a 6.0% year-over-year increase in the first half. This growth is directly fueled by escalating demand from the automotive electronics and AI server markets. As vehicles become more complex and data centers expand, the need for flawless electronic components skyrockets, making KohYoung’s precision inspection technology indispensable. The integration with their KPO Printer has further enhanced process optimization, creating a sticky ecosystem for customers.

Strategic Pivot in 3D AOI (Automated Optical Inspection)

While the 3D AOI segment faced headwinds from a smartphone market slowdown, KohYoung is proactively countering this with its AI-powered smart factory platform, ‘KSMART’. This platform moves beyond simple inspection to provide holistic process optimization solutions, integrating with other equipment on the manufacturing line. This value-add is crucial for expanding market share and demonstrating a clear technological advantage, mitigating cyclical weakness in specific end-markets.

Emerging Growth Engine: The KYMERO Medical Robot

Beyond its core inspection business, KohYoung is cultivating a powerful new growth driver in medical robotics. Sales of the KYMERO medical robot are gaining traction. Critically, the recent FDA approval of its ‘Geniant Cranial’ system opens the door to the lucrative U.S. market, creating a significant long-term revenue opportunity. This diversification into the high-growth surgical robot market, which you can read more about from analysts at reputable market research firms, is a key pillar of the company’s future.

Investment Outlook: Opportunities & Risks

The Q3 KohYoung earnings surprise has rightly generated bullish sentiment. However, a prudent investment strategy requires a balanced view of both the positive catalysts and potential risks on the horizon.

Positive Catalysts for Investors
- •Performance Momentum: The strong Q3 results create a powerful narrative of a company on the upswing, which can attract further investment.
- •Core Business Strength: Continued dominance in 3D SPI and a strategic recovery in AOI provide a stable foundation.
- •New Growth Vectors: The medical robot division is transitioning from a hopeful venture to a tangible contributor to future growth.
- •Technological Leadership: Over 20 years of expertise in 3D measurement and AI integration with ‘KSMART’ solidifies its #1 market share.
Potential Risks to Monitor

Despite the positive outlook, investors should remain aware of potential headwinds. Currency volatility remains a factor for any global exporter and can impact reported profits. Furthermore, broader macroeconomic uncertainty in the IT sector could affect client capital expenditures. Investors will be watching closely to see if this Q3 performance is a sustainable trend, a key factor in our ongoing analysis of the tech manufacturing sector.

Conclusion: A Brightening Future for KohYoung

The KohYoung Technology Inc. earnings for Q3 2025 are more than just a positive data point; they are a strong signal of a successful strategic execution and a potential inflection point for the company. The combination of a resilient core business, innovative AI-driven platforms, and a high-potential medical robotics division paints a compelling picture for future growth.

While investors should continue to monitor external risks, the fundamental trajectory for KohYoung appears decidedly positive. The recent results have firmly placed the company back on the path to sustained growth, making its stock (ticker: 098460) a compelling name to watch in the evolving tech landscape.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. The final responsibility for investment decisions rests solely with the investor.
11/05/2025
(098460) KohYoung Technology (098460) Analysis: Q3 Rebound & Medical Robot Future
Investors are closely watching KohYoung Technology Inc. (098460), a global powerhouse in 3D inspection equipment, as it prepares for its critical Q3 2025 Investor Relations (IR) conference on November 5, 2025. This event is pivotal, offering a chance to demonstrate a decisive rebound from a challenging first half and to showcase the burgeoning potential of its new growth engines, particularly in the high-stakes field of medical robotics.

With the landmark US FDA 510(k) clearance for its brain surgery medical robot, ‘Geniant Cranial,’ and the continuous evolution of its AI-powered smart factory platform, KSMART, KohYoung Technology is at a compelling inflection point. This analysis delves into the key factors shaping the company’s future, offering investors a comprehensive guide to what to watch for in the upcoming IR presentation.

Deconstructing the H1 2025 Performance

Understanding the Headwinds

The first half of 2025 presented a mixed picture for KohYoung Technology. According to its official filing (Source: Official Disclosure), consolidated revenue saw a slight decrease of 2.2% year-over-year to KRW 103.2 billion. The more significant concern for investors was the sharp decline in profitability:
- •Operating Profit: Plunged 49.3% to KRW 5.7 billion, largely due to planned increases in SG&A expenses and strategic R&D investments for future growth.
- •Net Income: Shifted to a net loss of KRW 1.5 billion, impacted by non-operating factors such as foreign exchange fluctuations.
- •Bright Spot: The 3D SPI (Solder Paste Inspection) division defied the trend, growing 6.0% thanks to robust demand from the automotive electronics and server sectors.
While concerning on the surface, the IR presentation will be a key opportunity for management to frame the increased spending as a necessary investment to fuel the next wave of innovation in both its core 3D inspection equipment and its nascent medical division.

Dual Pillars of Growth: Core Business & Medical Robotics

Dominance in 3D Inspection Equipment

KohYoung’s foundation remains its undisputed leadership in the SMT (Surface Mount Technology) inspection market. Its 3D inspection equipment, including AOI and SPI systems, is the gold standard for quality control in electronics manufacturing. This dominance is further enhanced by the KSMART platform, an AI-driven solution that moves beyond simple defect detection to provide process optimization, improving yields for clients in high-growth sectors like EVs and AI data centers. For more on the fundamentals of this technology, you can read our deep dive into 3D AOI technology.

The Future is Now: The KohYoung Medical Robot Division

The game-changer for KohYoung’s long-term valuation is the ‘Geniant Cranial’. FDA clearance opens the door to the lucrative US market, transforming the company from a pure-play industrial tech firm into a diversified MedTech innovator.

The KohYoung medical robot, ‘Geniant Cranial’, is a neurosurgical assistant robot designed to improve the precision and safety of complex brain surgeries. Receiving US FDA 510(k) clearance in January 2025 was a monumental achievement. This validation is critical for penetrating the global neurosurgery market, which, according to market research from firms like Grand View Research, is projected to grow at a CAGR exceeding 20%. With 4 units already supplied in 2024 for research and initial adoption, investors will be eager for updates on the commercial sales pipeline and go-to-market strategy during the IR call.

Key Watch Points for the Q3 IR Call

The IR call’s impact on KohYoung’s stock will hinge on management’s ability to provide clarity and confidence. Here are the most critical areas to monitor:
- •Q3 Financials & Q4 Guidance: Is there a clear top- and bottom-line recovery? What is the outlook for the final quarter of the year? A strong guidance could overshadow H1 weakness.
- •‘Geniant Cranial’ Commercial Traction: Beyond initial placements, are there confirmed sales orders? What is the feedback from early adopters? What is the sales strategy for the US and Europe?
- •KSMART Platform Progress: Concrete case studies or metrics on customer ROI from the KSMART platform would reinforce its value proposition and competitive moat.
- •Macro-Economic Strategy: How is the company navigating global supply chain issues, inflation, and fluctuating currency exchange rates?
Investment Outlook: A Prudent Approach

Investing in KohYoung Technology today requires a dual focus. The short-term picture is dependent on a demonstrable Q3 recovery in its core business. Any failure to provide a convincing turnaround story could lead to near-term volatility.

However, the long-term thesis is exceptionally compelling. The company’s entrenched leadership in a critical industrial technology, combined with a de-risked, high-growth venture into medical robotics, presents a powerful combination. A patient, long-term investment perspective seems warranted, but a cautious approach is advised until the details of the Q3 performance and the commercial roadmap for the KohYoung medical robot are fully clarified in the upcoming IR event. Prudent investors will analyze the IR results before making a final decision.
10/29/2025
(098460) KohYoung Technology IR: H1 2025 Analysis, Stock Risks & Growth Drivers
KohYoung Technology Inc. has presented a complex financial narrative for the first half of 2025, leaving investors with critical questions. While the company demonstrated operational resilience with an improved operating profit, a surprising net loss has cast a shadow over its performance. The upcoming KohYoung Technology IR (Investor Relations) conference on November 6th is now a pivotal moment for leadership to restore confidence and chart a clear path forward. This comprehensive KohYoung stock analysis will unpack the H1 2025 results, explore the underlying business trends, and outline the key factors that will determine the company’s trajectory.

Deconstructing the KohYoung H1 2025 Performance

At first glance, the KohYoung H1 2025 performance report is a study in contrasts. A marginal dip in revenue was offset by commendable cost management, but a sharp reversal to a net loss demands scrutiny.

A Tale of Two Profits
- •Revenue & Operating Profit: Revenue saw a slight year-on-year decrease of 2.2%, landing at KRW 103.2 billion. This was driven by a slowdown in the 3D AOI segment. However, operating profit impressively grew by 7.5% to KRW 5.7 billion, boosting the operating margin to 5.7%. This signals strong internal cost controls.
- •The Net Loss Reversal: The most alarming figure is the shift from a KRW 14.6 billion net profit in the prior year to a KRW 1.5 billion net loss. This was primarily caused by a massive surge in other non-operating expenses from KRW 0.56 billion to KRW 11.38 billion, a point that requires detailed explanation. For a granular breakdown, investors can consult the Official Disclosure (DART).
The core challenge for KohYoung is to prove that its profitability improvements are sustainable and that the non-operating expenses leading to the net loss are a one-off event, not a systemic issue. The upcoming KohYoung Technology IR is their main stage to make this case.

Business Segment Analysis: Strengths, Weaknesses, and Opportunities

A successful KohYoung investment strategy depends on understanding the performance of its individual business units. The company’s future hinges on the synergy between its established segments and its burgeoning new ventures.

3D SPI Business: The Reliable Engine

The 3D Solder Paste Inspection (SPI) segment remains a bright spot, showing robust growth of 6.0%. This is fueled by high demand from the automotive electronics and server industries. KohYoung’s dominant market share in the Surface Mount Technology (SMT) inspection market provides a stable foundation for the company’s revenue.

3D AOI Business: Facing Headwinds

The 3D Automated Optical Inspection (AOI) business experienced a 7.7% revenue decline, largely due to reduced orders from smartphone manufacturers. While the company is focusing on advanced AI-based solutions to regain momentum, this segment is susceptible to global economic volatility and shifting consumer electronics demand.

Medical Robotics: The KYMERO Growth Catalyst

Perhaps the most exciting long-term driver is the KYMERO medical robot. Following its U.S. FDA approval, this brain surgery medical robot is poised for entry into the lucrative North American market. As the demand for precision medicine and minimally invasive surgery grows—a trend confirmed by market analysis from sources like Bloomberg—KYMERO could become a significant new revenue stream and a core part of KohYoung’s future identity.

Investor Checklist for the Upcoming KohYoung Technology IR

The investor relations event on November 6th will be a crucial test of management’s transparency and strategic vision. Investors should listen carefully for clear answers to the following points:
- •Explanation for Net Loss: What were the specific non-operating expenses that caused the net loss, and what measures are in place to prevent a recurrence?
- •3D AOI Recovery Plan: What is the concrete strategy to reverse the decline in the AOI segment and expand into new markets beyond smartphones?
- •KYMERO Commercialization Roadmap: What are the specific timelines, sales targets, and market expansion plans for the KYMERO medical robot in North America and globally?
- •Liquidity and Inventory Management: How will the company address the decline in its current ratio and worsening inventory turnover to ensure financial stability?
Conclusion: A Pivotal Moment for Investor Confidence

This KohYoung Technology IR is more than just a financial update; it is an opportunity to redefine the company’s investment narrative. A successful presentation that transparently addresses concerns while powerfully showcasing its growth engines like KYMERO could lead to a positive re-evaluation of its stock. Conversely, an evasive or unclear performance could exacerbate market fears. For anyone considering a KohYoung investment, the insights from this event will be indispensable in shaping a well-informed strategy.
10/29/2025
(098460) KohYoung Technology IR (098460): A Deep Dive into Stock Impact & Investment Strategy
The upcoming KohYoung Technology IR event is a pivotal moment for investors monitoring the KOSDAQ market. As a global leader in 3D measurement-based inspection equipment, KohYoung Technology Inc. (098460) holds significant influence, and its investor communications can send powerful signals through the market. This Non-Deal Roadshow (NDR), scheduled for October 24th, is more than a standard update; it’s a critical opportunity for the company to shape its narrative, address market concerns, and outline its future trajectory. For investors, this event could either unlock new growth potential or reveal underlying challenges, making a thorough 098460 stock analysis more crucial than ever.

This in-depth guide will dissect the announcement, explore the potential dual-scenario impacts on KohYoung’s stock price, and provide a clear, actionable investment strategy for navigating the post-IR landscape. We will delve into what investors must watch for and how to interpret the information presented to make informed decisions.

The Upcoming KohYoung Technology IR: Official Details

KohYoung Technology Inc. officially announced its plan to engage with the investment community. According to the Official Disclosure (DART) filed on October 21, 2025, the company will host an Investor Relations (IR) meeting for domestic securities firms. The primary purpose is a Non-Deal Roadshow (NDR), a forum for management to provide updates without actively seeking capital.

Event at a Glance:
- •Company: KohYoung Technology Inc. (KOSDAQ: 098460)
- •Event Type: Investor Relations (IR) – Domestic NDR
- •Date & Time: October 24, 2025, 1:00 PM KST
- •Key Agenda: Presentation on recent business status, management performance, and an open Q&A session.
Analyzing the Potential Impact on KohYoung’s Stock Price

An investor relations event of this nature can create significant volatility. The market’s reaction will hinge entirely on the substance of the presentation and the confidence projected by the management team. Let’s examine the two primary scenarios.

The Bullish Scenario: Catalysts for a Stock Price Increase

A positive outcome could be triggered by several factors. If management presents stronger-than-expected earnings, a robust new order pipeline, or successful expansion into new markets (like medical robotics), investor sentiment could soar. Enhanced transparency from a detailed presentation builds trust. Furthermore, if the Q&A session effectively addresses lingering market concerns about competition or supply chain issues, it could attract a new wave of institutional investors, providing a strong tailwind for the KohYoung stock price.

The Bearish Scenario: Potential Risks and Headwinds

Conversely, the event carries downside risks. Acknowledgment of softening demand, margin compression, or performance figures that miss consensus estimates could trigger a sell-off. An evasive or unconvincing Q&A session can amplify uncertainty. External factors, such as negative macroeconomic data released around the same time, could also exacerbate a negative reaction. For a comprehensive view on market sentiment, investors often consult sources like Reuters Financial News for broader economic context.

The ultimate direction of KohYoung’s stock will be determined not by the event itself, but by the quality and credibility of the information shared. For investors, preparation and analysis are paramount.

Actionable Investment Strategy for Investors

Navigating the aftermath of the KohYoung Technology IR requires a structured approach. Investors should not react emotionally to initial price swings but instead focus on a systematic analysis of the new information.
- •Dissect the Presentation: Go beyond the headline numbers. Analyze trends in revenue, operating profit, and regional performance. Compare the newly disclosed data against previous guidance and analyst expectations to identify any ‘surprise’ elements.
- •Monitor Analyst Reports: Following the IR, securities firms will release updated reports. Pay close attention to changes in ratings, price targets, and earnings estimates. This provides a gauge of how professional analysts are interpreting the news.
- •Evaluate Management’s Vision: Listen closely to the long-term strategy. Are they discussing new technological innovations, market share expansion, or risk mitigation plans? A convincing long-term vision can often outweigh short-term performance dips.
- •Re-evaluate Fundamentals: Use the new data to update your own 098460 stock analysis. Does the company’s valuation still make sense? Our guide on performing fundamental analysis can provide a helpful framework.
Conclusion: A Turning Point for KohYoung (098460)

The KohYoung Technology IR event is a critical inflection point. While it introduces short-term uncertainty, it also offers invaluable transparency for the diligent investor. The outcome is not predetermined; it will be shaped by the strength of the company’s recent performance and the clarity of its future strategy. By focusing on in-depth analysis of the IR materials and monitoring the subsequent market reaction, investors can position themselves to make strategic, data-driven decisions rather than reactive trades.

Frequently Asked Questions (FAQ)

When is the KohYoung IR event scheduled?

KohYoung Technology Inc.’s Investor Relations (IR) event is scheduled for October 24, 2025, at 1:00 PM KST.

What is the purpose of the KohYoung IR event?

The purpose is to conduct a Non-Deal Roadshow (NDR) for domestic securities firms. The company will present its recent business status, management performance, and hold a Q&A session.

What are potential positive impacts on the KohYoung stock price?

Positive impacts could include a stock price increase driven by strong performance data, a confident outlook from management, and increased trust from the investment community, potentially attracting new institutional capital.

What should investors analyze after the KohYoung IR?

Investors should analyze the detailed financial figures presented, read updated reports from securities analysts, assess management’s long-term vision, and compare KohYoung’s performance with industry trends and competitors.
10/21/2025
Koh Young (098460) IR Presentation Analysis: Opportunity or Risk? (September 2025)
A Glimpse into Koh Young’s Future Through its IR Presentation

Koh Young held its IR presentation at the Shinhan Investment Corp. Corporate Day on September 26, 2025. Despite sluggish performance in the first half of the year, expectations remain high for the growth of the 3D SPI business and the potential of the medical robot business. This IR presentation serves as a critical turning point in gauging Koh Young’s future. This article analyzes the key takeaways from the presentation and highlights the important points for investors to consider.
1. Koh Young’s IR Presentation: What Was Discussed?

Koh Young recorded consolidated revenue of KRW 103.2 billion, operating profit of KRW 5.7 billion, and a net loss of KRW 1.5 billion in the first half of 2025. The 3D AOI business segment struggled due to decreased orders from smartphone clients, while the 3D SPI business segment showed solid growth thanks to increased demand from automotive electronics and servers. The FDA approval of the medical robot ‘Geniant Cranial’ is positive, but it has not yet translated into increased sales.

2. Reasons Behind the Sluggish Performance

The decline in the 3D AOI business segment is mainly attributed to a base effect compared to the same period last year. Increased R&D and SG&A expenses also contributed to the decline in profitability. The uncertain macroeconomic environment is also a burden.

3. Koh Young’s Future: Potential Opportunities

Koh Young expects a recovery in the 3D AOI business segment through the advancement of its AI-based smart factory platform ‘KSMART’ and expansion of its product lineup. The steady growth of the 3D SPI business segment and expansion of the medical robot business into the global market are also expected to be growth drivers.

4. Action Plan for Investors
- Thorough Analysis of the IR Presentation: Check the outlook for the 3D AOI business recovery, the performance of the KSMART platform, and plans for expanding medical robot sales.
- Monitoring Macroeconomic Variables: Continuously monitor the impact of macroeconomic variables such as interest rates, exchange rates, and raw material prices on Koh Young’s performance.
- Maintaining a Long-Term Perspective: It’s crucial to establish a long-term investment strategy considering Koh Young’s core competitiveness and growth potential, without being swayed by short-term performance fluctuations.
Q: How was Koh Young’s performance in the first half of 2025?

A: Koh Young recorded consolidated revenue of KRW 103.2 billion, operating profit of KRW 5.7 billion, and a net loss of KRW 1.5 billion. This represents a decline compared to the same period last year.

Q: What are Koh Young’s main business segments?

A: The main business segments are 3D AOI (Automated Optical Inspection), 3D SPI (Solder Paste Inspection), and medical robots.

Q: What is Koh Young’s future growth strategy?

A: Koh Young aims to achieve growth through the advancement of its AI-based smart factory platform ‘KSMART,’ expansion of the 3D SPI business, and entry into the global market for medical robots.
09/23/2025
Koh Young Stock Forecast: Insider Stake Sale, What Should Investors Do?
Koh Young’s stock price is showing concerning signs. Recent news of a stake sale by an insider of Koh Young Holdings has heightened investor concerns. Coupled with the company’s weak performance in the first half of 2025, uncertainty about Koh Young’s future is growing. This article analyzes the background of the stake sale and its short-term and long-term impacts, providing actionable strategies for investors.
What Happened at Koh Young?

On September 5, 2025, a public announcement revealed that Sung Jeong-gyu, an insider of Koh Young Holdings, sold 5,170 shares of Koh Young stock on the open market. This resulted in a slight decrease in Koh Young Holdings’ stake from 20.92% to 20.53%.

Why Is the Stake Sale a Concern?

While the decrease in stake itself is not substantial, combined with the weak performance in the first half of 2025, it could negatively impact investor sentiment. Caution is warranted, particularly because sales by major shareholders and insiders can raise concerns about the company’s future. The sale on the open market could also put downward pressure on the stock price in the short term.

What Should Investors Do?
- Monitor Further Stake Changes: Closely monitor any further stake changes by Koh Young Holdings and Sung Jeong-gyu. Continued selling could increase uncertainty regarding management control.
- Check for Fundamental Improvements: Verify whether there are fundamental improvements, such as sustained growth in the 3D SPI business, a rebound in the 3D AOI business, and visible results in the medical robot business.
- Consider Macroeconomic Factors: Analyze the impact of macroeconomic variables like interest rates, exchange rates, and global IT market trends on Koh Young.
- Adopt a Conservative Investment Approach: Given the current market conditions and the company’s fundamentals, a conservative approach to investment is recommended. It is advisable to wait for clear signals of fundamental improvement before making investment decisions.
Frequently Asked Questions

What is the reason for Koh Young Holdings’ stake sale?

According to the public announcement, the change in stake is due to a decrease in special relations and over-the-counter sales. The specific reason for the sale has not been disclosed.

What will be the impact of this stake sale on Koh Young’s stock price?

While the decrease in stake itself is not significant, coupled with the current weak earnings, it could lead to worsening investor sentiment and downward pressure on the stock price in the short term. The long-term impact will depend on whether fundamentals improve and whether there are further stake changes.

Should I invest in Koh Young?

Considering the current market situation and the company’s fundamentals, a conservative approach is recommended. It’s best to wait for clear signs of fundamental improvement before making investment decisions.
09/05/2025